The Number One That Means Something and the Number One That Doesn't

CBS Sports published their weekly power rankings on Monday. The Atlanta Braves sit at number one. The Los Angeles Dodgers, defending champions, two-time World Series winners in three years, sit at number two.

This is not a controversial ranking. It might be the least controversial claim Matt Snyder has made all season.

Twenty wins and nine losses. A .690 winning percentage. A plus-65 run differential — the largest in Major League Baseball. The Braves have not lost a series in 2026. Their worst stretch was a four-game split against Arizona, which is the kind of blemish that makes the rest of the record look even more absurd by comparison.

But power rankings are decorative. They tell you what happened. The interesting question is what the numbers underneath them predict.

Bill James invented the Pythagorean expectation in the 1980s as a way to estimate how many games a team should have won based on runs scored and runs allowed. The formula is simple: runs scored squared, divided by the sum of runs scored squared and runs allowed squared. It's not perfect — no model is — but over a full season it tends to land within three or four wins of the actual record.

Through 29 games, the Braves have scored 166 runs and allowed 101. The Pythagorean formula produces an expected winning percentage of .730.

Over 162 games, that projects to 118 wins.

One hundred and eighteen. The 2001 Seattle Mariners won 116 games and hold the American League record. The 1906 Cubs won 116 in a 154-game season. Nobody in modern baseball history has won 118.

This is, of course, absurd. The Braves will not win 118 games. Regression happens. Injuries happen. August in the NL East happens. But the projection is useful not as a prediction but as a diagnostic: the plus-65 run differential is not the product of a few blowout wins inflating the number. The Braves are winning the way sustainable teams win — by outscoring opponents consistently, not catastrophically.

Snyder's piece draws the comparison to the 2021-2023 Braves, and this is where the analysis gets interesting.

The 2021 Braves won the World Series. They did so with a record of 88-73 — one of the lowest winning percentages for a World Series champion in the 21st century — and they were 51-52 at the trade deadline before a second-half surge that remains one of the most unlikely championship runs in modern memory. That team bore no statistical resemblance to the 2026 club. Comparing the two is like comparing a house that survived a hurricane to a house that was never in the storm's path.

The 2022 Braves won 101 games. The 2023 Braves won 104, posted a plus-231 run differential — the largest in baseball that year — and set franchise records for wins, home runs, and run production. Those teams were built on an extraordinary confluence of talent and health: Ronald Acuña Jr.'s MVP season, a rotation anchored by Spencer Strider striking out batters at a rate the league hadn't seen in years, and a lineup where the power ran seven deep.

The 2026 Braves look different.

The rotation ERA is among the best in the majors — but three-fifths of the projected opening day rotation began the season on the injured list. Chris Sale, at 37, is pitching better than his 2024 Cy Young season. Bryce Elder, who posted a 5.30 ERA last year, has a 1.95 in 2026. Martín Pérez signed a minor-league deal in January and carries a 2.70 ERA. Reynaldo López has been reliable. The depth is real. It is also constructed almost entirely from contingency plans.

The offense tells a more conventional story. Michael Harris II is slashing .323/.360/.559 through 29 games — a confirmation of the barrel-rate and exit-velocity improvements Statcast identified last fall. Matt Olson has eight home runs and is slugging over .600, which is the Olson the Braves paid $168 million for in 2022, finally and fully arrived. Ozzie Albies is hitting .316. Drake Baldwin, the sophomore catcher, is at .311 with seven home runs and 25 RBI.

The exception is Ronald Acuña Jr., who is hitting .239 with two home runs — the kind of April line that would cause alarm if it weren't Acuña, and still causes quiet concern because even Acuña has limits on how much a slow start can be dismissed.

The comparison that CBS Sports should have made is not to the 2021-2023 Braves. It is to the 2025 Braves.

Last season — 76 wins, 86 losses. Ten games under .500. First playoff miss since 2017. The most disappointing team in baseball, by a margin that felt almost intentional. Injuries gutted the rotation. The lineup produced at replacement level for stretches that lasted weeks. The bullpen held leads with the reliability of a paper umbrella.

The gap between 76-86 and 20-9 through 29 games is not explicable by roster talent alone. The talent was there in 2025 — Sale when healthy, Olson when locked in, Harris on the verge of the breakout that arrived in 2026 instead. What changed is health, and health is not a plan. It is a condition.

Snyder is right that the Braves are the best team in baseball. The run differential says so. The series record says so. The Pythagorean projection, in its cheerful mathematical way, says so emphatically. But being the best team in baseball in April is a fact about April. The same run differential applied to 2025's injured roster would have produced the same projection and the same catastrophe.

What makes me cautiously optimistic — and I use that word with the deliberateness it deserves, because this franchise has taught me that the distance between optimism and heartbreak is shorter than any run differential — is the structure beneath the numbers.

I wrote two weeks ago that the series record with three-fifths of the rotation injured was structural, not a streak. That position has strengthened. The bullpen chain that carried the early weeks has not broken. The bats that appeared in April have not vanished in the way April bats sometimes do. Sale has made six starts, and five of them have been the kind of starts that make you reconsider what age means for a left-hander with elite command.

But Strider has not returned yet. His rehabilitation is progressing — an early May return remains the target — and when he arrives, the question shifts from whether the depth can sustain itself to what a rotation with both Sale and Strider looks like in August. That is the variable CBS Sports cannot account for in a power ranking, and it is the variable that separates a 95-win season from the kind of October run this franchise hasn't made since 2021.

The number one ranking is earned. Twenty-nine games is not a small sample — it is a quarter of a season, and the data is directional. But rankings are snapshots. Run differentials are signals. The signal says the Braves are not a team riding luck or a soft schedule. They are producing runs and preventing them at a rate that the mathematics of baseball interpret as genuinely elite.

Whether they stay elite depends on things a power ranking cannot measure: the health of a 37-year-old arm, the second-half durability of a catcher in his sophomore year, and the return of a pitcher whose velocity is the single largest variable in any projection model applied to this roster.

The Braves are number one. The question that matters is what kind of number one they'll be in September.